Brief: Y-Mabs Announces Outcome Of FDA Advisory Committee Meeting On Omburtamab

Y-mAbs Therapeutics

28/10/2022 20:34

Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS ANNOUNCES OUTCOME OF FDA ADVISORY COMMITTEE MEETING
ON
OMBURTAMAB
    * Y-MABS THERAPEUTICS - COMMITTEE VOTED 16 TO 0 THAT COMPANY
HAD
NOT PROVIDED SUFFICIENT EVIDENCE TO CONCLUDE THAT OMBURTAMAB
IMPROVES OVERALL SURVIVAL.

Source text for Eikon:  ID:nGNX8K4TXG 
Further company coverage:  YMAB.O